From Optimism to Disillusion about Commitment to Transparency in the Medico-Industrial Complex

This publication has 16 references indexed in Scilit:

• Clinical trial registration: transparency is the watchword
  The Lancet, 2006
• Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
  American Journal of Psychiatry, 2006
• At the frontier of biomedical publication: Chicago 2005
  BMJ, 2005
• Open access to industry's clinically relevant data
  BMJ, 2004
• Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
  BMJ, 2003
• Pharmaceutical industry sponsorship and research outcome and quality: systematic review
  BMJ, 2003
• The uncertainty principle and industry-sponsored research
  The Lancet, 2000
• First Report of the Ethics Sub-Group
  International Journal of Pharmaceutical Medicine, 2000
• Underreporting Research Is Scientific Misconduct
  JAMA, 1990
• Study of information submitted by drug companies to licensing authorities.
  BMJ, 1980